MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that an abstract detailing a potential ...

UCB, a global biopharmaceutical company, today announced positive data from studies involving its investigational pyrimidine nucleoside therapy, doxecitine (dC) and doxribtimine (dT), in people living ...

New genetic research suggests that humans first developed language around 135,000 years ago when populations began ...

MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announces the publication of preclinical data for ...

DNA is fundamental to the biology of all life on Earth, but how many of us actually know what it is or what it's made of?

Millions of Americans who sent their saliva to 23andMe in the hopes of finding lost relatives or identifying health risks ...

Stay connected with the latest updates on international politics, economic changes, conflicts, environmental issues, and more ...

This study provides compelling evidence that kinesin's stepping mechanism is governed by strain-induced conformational changes in its nucleotide-binding pockets. Using pre-steady state kinetics and ...

MAIA Biotechnology Receives USAN Council Approval for "Ateganosine" as Nonproprietary Name for Anticancer Agent THIO ...

France 15 Year Government Bond 0.000 3.779% ...